Clinical Trials Logo

Clinical Trial Summary

This study compares the equivalence of hyperpolarized 129Xe MRI to 133Xe scintigraphy for the evaluation of pulmonary function in patients being evaluated for lung transplant.


Clinical Trial Description

This is a multicenter, randomized, open-label, cross-over Phase 3 study evaluating hyperpolarized 129Xe gas MRI as compared to 133Xe scintigraphy for the evaluation of pulmonary function. This study will enroll subjects being evaluated for possible lung transplant surgery (either single or bilateral) . Subjects will have both a 129Xe MRI and 133Xe scintigraphy image. The vast differences in technique for obtaining hyperpolarized 129Xe MRI as compared to 133Xe scintigraphy make it impossible to blind study procedures. However, all image interpretation will be performed by personnel blinded to the subject's medical history and all study assessments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03418090
Study type Interventional
Source Polarean, Inc.
Contact
Status Completed
Phase Phase 3
Start date August 17, 2018
Completion date November 4, 2019

See also
  Status Clinical Trial Phase
Completed NCT01255033 - Oxygen Peripheral Saturations and Lung Surgery N/A
Completed NCT00925444 - Staple-line Reinforcement for Prevention of Pulmonary Air Leakage Phase 4
Completed NCT05126524 - Loco-regional Anaesthesia in Video or Robot-assisted Thoracic Pulmonary Surgery
Recruiting NCT05600569 - Registry of the Spanish Society of Thoracic Surgery
Completed NCT03417687 - Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection Phase 3
Completed NCT02376218 - Post-lobectomy Use of Glucose for Pleurodesis and Air-leak Cessation. A Feasibility Trial. N/A